ACVRL1 and prostate carcinoma: Besides, treatment with ALK1-Fc also showed an effect in the tumor cell compartment, since in orthotopic models of prostate cancer the inhibition of ALK1 with ALK1-Fc decreased BMP9-induced signaling, the proliferation of tumor cells and tumor growth.